Acrivon Therapeutics (ACRV) Cash from Investing Activities (2021 - 2026)
Acrivon Therapeutics' Cash from Investing Activities was $14.95 million in Q2 2026, down 23.2% from $19.45 million a year earlier but up 13.9% from the prior quarter.
Powered by 
Analysis
Acrivon Therapeutics (ACRV) Cash from Investing Activities (2021 - 2026) Analysis & Trends
On a trailing twelve-month basis, Acrivon Therapeutics' Cash from Investing Activities was $55.51 million through Jun 30, 2026, down 19.7% year-over-year; for FY2025, it came in at $66.1 million.
- In earlier years, Cash from Investing Activities was -$51.77 million in FY2024, $50.72 million in FY2023, -$141.68 million in FY2022 and -$238,000 in FY2021.
- Quarterly Cash from Investing Activities has moved between -$95.07 million (Q4 2022) and $21.52 million (Q4 2025) over five years.
- Compared with a year earlier, Cash from Investing Activities was higher in three of the last seven quarters, with growth averaging 155.2%.
- The best year-over-year quarter for Cash from Investing Activities over five years was Q3 2024 (growth of 956.1%); the worst was Q3 2025 (a decline of 63.1%).
- Per Business Quant data, ACRV's Cash from Investing Activities in the three quarters before Q2 2026 was $13.13 million (Q1 2026), $21.52 million (Q4 2025) and $5.91 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | -15.40 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | -1.11 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | -1.20 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -5.60 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.11 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -2.91 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | -569.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.35 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 2.11 Bn |
| 10 | Acrivon Therapeutics | 85.27 Mn | 85.27 Mn | - | 14.95 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.95 Mn |
| Mar 31, 2026 | 13.13 Mn |
| Dec 31, 2025 | 21.52 Mn |
| Sep 30, 2025 | 5.91 Mn |
| Jun 30, 2025 | 19.45 Mn |
| Mar 31, 2025 | 19.21 Mn |
| Dec 31, 2024 | 14.41 Mn |
| Sep 30, 2024 | 16.01 Mn |
| Jun 30, 2024 | -88.04 Mn |
| Mar 31, 2024 | 5.85 Mn |
| Dec 31, 2023 | 20.54 Mn |
| Sep 30, 2023 | 1.52 Mn |
| Jun 30, 2023 | 19.34 Mn |
| Mar 31, 2023 | 9.33 Mn |
| Dec 31, 2022 | -95.07 Mn |
| Sep 30, 2022 | -45.12 Mn |
| Jun 30, 2022 | -1.07 Mn |
| Mar 31, 2022 | -415,000.00 |
| Dec 31, 2021 | -137,000.00 |
API Access
Acrivon Therapeutics Cash from Investing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=ACRV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-investing-activities", "ticker": "ACRV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=ACRV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();